Pacemaker News and Research RSS Feed - Pacemaker News and Research

St. Jude Medical receives CE Mark approval for Quadra Allure MP CRT-P

St. Jude Medical receives CE Mark approval for Quadra Allure MP CRT-P

St. Jude Medical, Inc., a global medical device company, today announced CE Mark approval of the Quadra Allure MP™ cardiac resynchronization therapy pacemaker (CRT-P). [More]
Advances in fight against TB, sudden cardiac death

Advances in fight against TB, sudden cardiac death

Research projects into two of the biggest killers in worldwide health, tuberculosis and sudden cardiac death, will be the subjects of the University of Leicester Graduate School Doctoral Inaugural Lectures, delivered by two of the winners of this year's PhD prizes in the College of Medicine, Biological Sciences and Engineering. [More]
Preterm birth becomes world's number one killer of young children

Preterm birth becomes world's number one killer of young children

For the first time in history, the complications of preterm birth outrank all other causes as the world's number one killer of young children. [More]
University at Buffalo researchers receive $500,000 grant to study IED-induced vision loss

University at Buffalo researchers receive $500,000 grant to study IED-induced vision loss

It's well known that battlefield explosions can cause hearing loss, but veterans may be surprised to learn that their vision may also suffer — sometimes weeks or months after combat exposure. [More]
SCN clock isn't necessary to align body rhythms with light-dark cycle, study reveals

SCN clock isn't necessary to align body rhythms with light-dark cycle, study reveals

Circadian clocks regulate functions ranging from alertness and reaction time to body temperature and blood pressure. New research published in the November 2014 issue of The FASEB Journal further adds to our understanding of the circadian rhythm by suggesting that the suprachiasmaticus nucleus (SCN) clock, a tiny region of the hypothalamus considered to be the body's "master" timekeeper, is not necessary to align body rhythms with the light-dark cycle. [More]
BHVH cardiologists implant investigational cardiac pacemaker the size of multivitamin

BHVH cardiologists implant investigational cardiac pacemaker the size of multivitamin

Cardiologists on the medical staff at Baylor Jack and Jane Hamilton Heart and Vascular Hospital (BHVH) today implanted an investigational cardiac pacemaker the size of a multivitamin. [More]
Researchers discover rare disease that affects heart rate, intestinal movements

Researchers discover rare disease that affects heart rate, intestinal movements

Physicians and researchers at CHU Sainte-Justine, Universit- de Montr-al, CHU de Qu-bec, Universit- Laval, and Hubrecht Institute have discovered a rare disease affecting both heart rate and intestinal movements. [More]
EnteroMedics' CE Mark for Maestro System expanded to include management of Type 2 diabetes mellitus

EnteroMedics' CE Mark for Maestro System expanded to include management of Type 2 diabetes mellitus

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that its CE Mark for the Maestro Rechargeable (RC) System for obesity was expanded to include the management of Type 2 diabetes mellitus through improved glycemic control. [More]
St. Jude Medical gets CE Mark approval for updated labeling of Tendril STS, IsoFlex Optim pacing leads

St. Jude Medical gets CE Mark approval for updated labeling of Tendril STS, IsoFlex Optim pacing leads

St. Jude Medical, Inc., a global medical device company, today announced CE Mark approval of updated labeling for its Tendril STS and IsoFlex Optim pacing leads, allowing existing and future patients with the devices access to magnetic resonance imaging (MRI) scans. [More]
Soledad Senga honored with AHA's Lifestyle Change Award

Soledad Senga honored with AHA's Lifestyle Change Award

Brown & Toland Physicians, a leading network of independent doctors, honored Soledad Senga on Friday with the Lifestyle Change Award at the annual American Heart Association San Francisco Heart Walk kick-off at Justin Herman Plaza. [More]
Amgen announces phase 3 ivabradine data for treatment of chronic HF

Amgen announces phase 3 ivabradine data for treatment of chronic HF

Amgen (NASDAQ: AMGN) today announced data from the Phase 3 SHIFT (Systolic Heart failure treatment with the If inhibitor ivabradine Trial) study evaluating ivabradine in patients with chronic heart failure (HF) were presented at the 18th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) in Las Vegas. [More]
Permanent atrial fibrillation twins risk of stroke than paroxysmal AF

Permanent atrial fibrillation twins risk of stroke than paroxysmal AF

Permanent atrial fibrillation (AF) doubles the risk of stroke compared to paroxysmal AF, according to research in more than 6 000 patients presented at ESC Congress today by Dr Thomas Vanassche from Belgium. The findings suggest that a simple clinical assessment of the type of AF can help doctors to better estimate stroke risk. [More]
Extracting Cardiac Leads: An Interview with Barry Norlander from Cook Medical

Extracting Cardiac Leads: An Interview with Barry Norlander from Cook Medical

The pacemaker or ICD unit, which is the implanted box or generator i.e. the electrical component of the device that's implanted in the chest, usually lasts between seven to 10 years before the generator’s battery is depleted. [More]
Researcher presents new batteryless cardiac pacemaker based on automatic wristwatch

Researcher presents new batteryless cardiac pacemaker based on automatic wristwatch

A new batteryless cardiac pacemaker based on an automatic wristwatch and powered by heart motion was presented at ESC Congress 2014 today by Adrian Zurbuchen from Switzerland. The prototype device does not require battery replacement. [More]
Amgen's ivabradine receives FDA priority review designation for treatment of chronic heart failure

Amgen's ivabradine receives FDA priority review designation for treatment of chronic heart failure

Amgen today announced the U.S. Food and Drug Administration has granted priority review designation for ivabradine for the treatment of chronic heart failure (HF). [More]
Remote monitoring of implanted pacemakers and defibrillators: an interview with Dr. Suneet Mittal

Remote monitoring of implanted pacemakers and defibrillators: an interview with Dr. Suneet Mittal

Remote monitoring is the ability to follow patients who have implantable pacemakers or defibrillators from home. This technology was introduced in the U.S. in 2001 so it’s been available for close to 15 years. [More]
Biomedical engineering professor wins prestigious 2014 Early Career Achievement Award

Biomedical engineering professor wins prestigious 2014 Early Career Achievement Award

Qi Wang, assistant professor of biomedical engineering, recently won the prestigious 2014 Early Career Achievement Award from the IEEE Engineering in Medicine and Biology Society (EMBS). [More]
First peer-reviewed comprehensive expert guidance on the use of neurostimulation for pain

First peer-reviewed comprehensive expert guidance on the use of neurostimulation for pain

Reflecting groundbreaking international consensus regarding a group of rapidly evolving medical interventions for chronic pain, the International Neuromodulation Society announced it will soon publish the first peer-reviewed comprehensive expert guidance on the appropriate use of neurostimulation for pain. [More]
EnteroMedics reports net loss of $7.5 million for Q2 2014

EnteroMedics reports net loss of $7.5 million for Q2 2014

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced financial results for the three and six months ended June 30, 2014. [More]
Gene therapy offers potential alternative to pacemakers

Gene therapy offers potential alternative to pacemakers

Researchers have developed a gene transplant procedure that can transform ordinary heart muscle cells into “biological pacemaker” cells that maintain heart rhythm. [More]